Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Bassel Alsaed

Showing results (1-10 of 5) with videos related to

Pageof 1
Sort By:
Proceedings. Biological Sciences|December 10, 2024
Extending evolutionary forecasts across bacterial speciesJennifer T Pentz, Aparna Biswas, Bassel Alsaed, et al.
Cancer Metastasis Reviews|June 16, 2025
Shaping the battlefield: EGFR and KRAS tumor mutations' role on the immune microenvironment and immunotherapy responses in lung cancerBassel Alsaed, Nina Bobik, Hanna Laitinen, et al.
Science Advances|October 30, 2024
Ex vivo modeling of precision immuno-oncology responses in lung cancerBassel Alsaed, Johannes Smolander, Hanna Laitinen, et al.
Nature Communications|January 2, 2025
Intratumor heterogeneity of EGFR expression mediates targeted therapy resistance and formation of drug tolerant microenvironmentBassel Alsaed, Linh Lin, Jieun Son, et al.
Cell Reports Methods|June 4, 2026
Precision tumor-on-chip for personalized assessment of drug efficacy and immune cell deliveryElena Kremneva, Johannes Smolander, Mimosa Peltokangas, et al.
Pageof 1

Showing results (1-10 of 5) with videos related to

Sort By:
Pageof 1
Proceedings. Biological Sciences|December 10, 2024
Extending evolutionary forecasts across bacterial speciesJennifer T Pentz, Aparna Biswas, Bassel Alsaed, et al.
Cancer Metastasis Reviews|June 16, 2025
Shaping the battlefield: EGFR and KRAS tumor mutations' role on the immune microenvironment and immunotherapy responses in lung cancerBassel Alsaed, Nina Bobik, Hanna Laitinen, et al.
Science Advances|October 30, 2024
Ex vivo modeling of precision immuno-oncology responses in lung cancerBassel Alsaed, Johannes Smolander, Hanna Laitinen, et al.
Nature Communications|January 2, 2025
Intratumor heterogeneity of EGFR expression mediates targeted therapy resistance and formation of drug tolerant microenvironmentBassel Alsaed, Linh Lin, Jieun Son, et al.
Cell Reports Methods|June 4, 2026
Precision tumor-on-chip for personalized assessment of drug efficacy and immune cell deliveryElena Kremneva, Johannes Smolander, Mimosa Peltokangas, et al.
Pageof 1